BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7512602)

  • 1. Acquired C1 inhibitor deficiency as a result of an autoantibody to the reactive center region of C1 inhibitor.
    Mandle R; Baron C; Roux E; Sundel R; Gelfand J; Aulak K; Davis AE; Rosen FS; Bing DH
    J Immunol; 1994 May; 152(9):4680-5. PubMed ID: 7512602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epitope mapping of C1 inhibitor autoantibodies from patients with acquired C1 inhibitor deficiency.
    He S; Tsang S; North J; Chohan N; Sim RB; Whaley K
    J Immunol; 1996 Mar; 156(5):2009-13. PubMed ID: 8596057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angioneurotic edema with acquired C1- inhibitor deficiency and autoantibody to C1- inhibitor: response to plasmapheresis and cytotoxic therapy.
    Donaldson VH; Bernstein DI; Wagner CJ; Mitchell BH; Scinto J; Bernstein IL
    J Lab Clin Med; 1992 Apr; 119(4):397-406. PubMed ID: 1583391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibody-mediated acquired deficiency of C1 inhibitor.
    Alsenz J; Bork K; Loos M
    N Engl J Med; 1987 May; 316(22):1360-6. PubMed ID: 3494945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibody facilitated cleavage of C1-inhibitor in autoimmune angioedema.
    Jackson J; Sim RB; Whaley K; Feighery C
    J Clin Invest; 1989 Feb; 83(2):698-707. PubMed ID: 2536404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyclonal autoantibodies against C1 inhibitor in a case of acquired angioedema.
    Ponce IM; Caballero T; Reche M; Piteiro AB; López-Serrano MC; Fontán G; López-Trascasa M
    Ann Allergy Asthma Immunol; 2002 Jun; 88(6):632-7. PubMed ID: 12086372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired C1 inhibitor (C1-INH) deficiency type II. Replacement therapy with C1-INH and analysis of patients' C1-INH and anti-C1-INH autoantibodies.
    Alsenz J; Lambris JD; Bork K; Loos M
    J Clin Invest; 1989 Jun; 83(6):1794-9. PubMed ID: 2723058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [C1 inhibitor deficiency. Heredity and acquired forms. Symptoms, diagnostic and therapeutic problems].
    Obtułowicz K; Kapusta M; Obtułowicz A; Mazurkiewicz A
    Przegl Lek; 2002; 59(6):438-41. PubMed ID: 12418282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chymotrypsin inhibitory activity of normal C1-inhibitor and a P1 Arg to His mutant: evidence for the presence of overlapping reactive centers.
    Aulak KS; Davis AE; Donaldson VH; Harrison RA
    Protein Sci; 1993 May; 2(5):727-32. PubMed ID: 8495195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathophysiology of hereditary angioedema.
    Davis AE
    Clin Immunol; 2005 Jan; 114(1):3-9. PubMed ID: 15596403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C1 subcomponent complexes: basic and clinical aspects.
    Laurell AB; Sjöholm AG
    Behring Inst Mitt; 1993 Dec; (93):292-8. PubMed ID: 8172579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C1 esterase inhibitor deficiency: three presentations.
    Baldwin J; Pence HL; Karibo JM; Massey EN
    Ann Allergy; 1991 Aug; 67(2 Pt 1):107-13. PubMed ID: 1867444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibody-mediated acquired deficiency of C1 inhibitor.
    Jackson J; Feighery C
    N Engl J Med; 1988 Jan; 318(2):122-3. PubMed ID: 3336393
    [No Abstract]   [Full Text] [Related]  

  • 14. C1 Inhibitor as a glycoprotein: The influence of polysaccharides on its function and autoantibody target.
    Ghannam A; Sellier P; Fain O; Martin L; Ponard D; Drouet C
    Mol Immunol; 2016 Mar; 71():161-165. PubMed ID: 26897339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A simplified method for the assessment of C1 esterase inhibitor function].
    Deguchi M; Takemura S; Ueda M; Kasamatsu Y; Yanagida K; Fukuda W; Okamoto M; Onodera H; Sugino S; Kondo M
    Ryumachi; 1990 Jun; 30(3):166-71. PubMed ID: 2244251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and characterization of two functionally distinct forms of C1 inhibitor from a patient with angioedema.
    Curd JG; Yelvington M; Ziccardi RJ; Mathison DA; Griffin JH
    Clin Exp Immunol; 1981 Aug; 45(2):261-70. PubMed ID: 6976242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired C1-inhibitor deficiency associated with a lupus-like anticoagulant activity.
    Rodriguez M; Ancochea J; De Buen C; Merino JL; Marqués G; Vivanco F
    Ann Allergy; 1988 Nov; 61(5):348-50. PubMed ID: 3142311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unique C1 inhibitor dysfunction in a kindred without angioedema. I. A mutant C1 INH that inhibits C1-s but not C1-r.
    Wisnieski JJ; Knauss TC; Yike I; Dearborn DG; Narvy RL; Naff GB
    J Immunol; 1994 Mar; 152(6):3199-209. PubMed ID: 8144914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An autoantibody to C1-inhibitor recognizes the reactive center of the inhibitor.
    Donaldson VH; Wagner CJ; Davis AE
    J Lab Clin Med; 1996 Feb; 127(2):229-32. PubMed ID: 8636653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of action of anti-C1-inhibitor autoantibodies: prevention of the formation of stable C1s-C1-inh complexes.
    He S; Sim RB; Whaley K
    Mol Med; 1998 Feb; 4(2):119-28. PubMed ID: 9508789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.